OBJECTIVE: To better understand the postprandial clearance of triglyceride-rich lipoproteins (TRLs) and its relation to the fasting kinetics of TRLs. METHODS: Two studies were performed on 30 male subjects: a fasting kinetic study to determine the fasting secretion and clearance rates of apolipoprotein B (apoB) 100 and triglycerides in the very low-density lipoprotein 1 and 2 (VLDL(1) and VLDL(2)) fractions; and a postprandial study to determine the postprandial accumulation of apoB48, apoB100 and triglycerides in the chylomicron, VLDL(1) and VLDL(2) fractions. Results from these two studies were combined to characterize the postprandial clearance of TRLs in a physiologically relevant setting. RESULTS: Our results show that postprandial accumulation of the apoB48-carrying chylomicrons can be predicted from the clearance capacity of the lipolytic pathway, determined in the fasting state. Furthermore, we show that chylomicrons and VLDL(1) particles are not cleared equally by the lipoprotein lipase pathway, and that chylomicrons seem to be the preferred substrate. Subjects with a rapid fasting lipid metabolism accumulate lower levels of postprandial triglycerides with less accumulation of apoB100 in the VLDL(1) fraction and a faster transfer of apoB100 into the VLDL(2) fraction. In contrast, fasting VLDL(1) secretion does not predict postprandial triglyceride accumulation. CONCLUSIONS: Non-fasting triglyceride levels have recently been identified as a major predictor of future cardiovascular events. Here we show that the capacity of the lipolytic pathway is a common determinant of both the fasting and non-fasting triglyceride levels and may thus play an important role in the development of dyslipemia and atherosclerosis.
OBJECTIVE: To better understand the postprandial clearance of triglyceride-rich lipoproteins (TRLs) and its relation to the fasting kinetics of TRLs. METHODS: Two studies were performed on 30 male subjects: a fasting kinetic study to determine the fasting secretion and clearance rates of apolipoprotein B (apoB) 100 and triglycerides in the very low-density lipoprotein 1 and 2 (VLDL(1) and VLDL(2)) fractions; and a postprandial study to determine the postprandial accumulation of apoB48, apoB100 and triglycerides in the chylomicron, VLDL(1) and VLDL(2) fractions. Results from these two studies were combined to characterize the postprandial clearance of TRLs in a physiologically relevant setting. RESULTS: Our results show that postprandial accumulation of the apoB48-carrying chylomicrons can be predicted from the clearance capacity of the lipolytic pathway, determined in the fasting state. Furthermore, we show that chylomicrons and VLDL(1) particles are not cleared equally by the lipoprotein lipase pathway, and that chylomicrons seem to be the preferred substrate. Subjects with a rapid fasting lipid metabolism accumulate lower levels of postprandial triglycerides with less accumulation of apoB100 in the VLDL(1) fraction and a faster transfer of apoB100 into the VLDL(2) fraction. In contrast, fasting VLDL(1) secretion does not predict postprandial triglyceride accumulation. CONCLUSIONS: Non-fasting triglyceride levels have recently been identified as a major predictor of future cardiovascular events. Here we show that the capacity of the lipolytic pathway is a common determinant of both the fasting and non-fasting triglyceride levels and may thus play an important role in the development of dyslipemia and atherosclerosis.
Authors: Latisha Love-Gregory; Aldi T Kraja; Fiona Allum; Stella Aslibekyan; Åsa K Hedman; Yanan Duan; Ingrid B Borecki; Donna K Arnett; Mark I McCarthy; Panos Deloukas; Jose M Ordovas; Paul N Hopkins; Elin Grundberg; Nada A Abumrad Journal: J Lipid Res Date: 2016-10-11 Impact factor: 5.922
Authors: Elizabeth A O'Hare; Rongze Yang; Laura M Yerges-Armstrong; Urmila Sreenivasan; Rebecca McFarland; Carmen C Leitch; Meredith H Wilson; Shilpa Narina; Alexis Gorden; Kathy A Ryan; Alan R Shuldiner; Steve A Farber; G Craig Wood; Christopher D Still; Glenn S Gerhard; Janet D Robishaw; Carole Sztalryd; Norann A Zaghloul Journal: Hepatology Date: 2017-03-22 Impact factor: 17.425
Authors: Maxine P Bonham; Kaisa M Linderborg; Aimee Dordevic; Amy E Larsen; Kay Nguo; Jacquelyn M Weir; Petra Gran; Marika K Luotonen; Peter J Meikle; David Cameron-Smith; Heikki P T Kallio; Andrew J Sinclair Journal: Lipids Date: 2012-11-03 Impact factor: 1.880
Authors: Antti Hakkarainen; Jesper Lundbom; Esa K Tuominen; Marja-Riitta Taskinen; Kirsi H Pietiläinen; Nina Lundbom Journal: MAGMA Date: 2014-06-04 Impact factor: 2.310
Authors: Stephanie T Chung; Celeste K L Cravalho; Abby G Meyers; Amber B Courville; Shanna Yang; Nirupa Rachel Matthan; Lilian Mabundo; Maureen Sampson; Ronald Ouwerkerk; Ahmed M Gharib; Alice H Lichtenstein; Alan T Remaley; Anne E Sumner Journal: Circ Res Date: 2019-10-18 Impact factor: 17.367